Reprogramming alveolar macrophage responses to TGF-β reveals CCR2+ monocyte activity that promotes bronchiolitis obliterans syndrome.

MLA

Zhiyi Liu, et al. “Reprogramming Alveolar Macrophage Responses to TGF-β Reveals CCR2+ Monocyte Activity That Promotes Bronchiolitis Obliterans Syndrome.” Journal of Clinical Investigation, vol. 132, no. 19, Oct. 2022, pp. 1–18. EBSCOhost, https://doi.org/10.1172/JCI159229.

APA

Zhiyi Liu, Fuyi Liao, Jihong Zhu, Dequan Zhou, Gyu Seong Heo, Leuhmann, H. P., Scozzi, D., Parks, A., Hachem, R., Byers, D. E., Tague, L. K., Kulkarni, H. S., Cano, M., Wong, B. W., Wenjun Li, Huang, H. J., Krupnick, A. S., Kreisel, D., Yongjian Liu, & Gelman, A. E. (2022). Reprogramming alveolar macrophage responses to TGF-β reveals CCR2+ monocyte activity that promotes bronchiolitis obliterans syndrome. Journal of Clinical Investigation, 132(19), 1–18. https://doi.org/10.1172/JCI159229

Chicago

Zhiyi Liu, Fuyi Liao, Jihong Zhu, Dequan Zhou, Gyu Seong Heo, Hannah P. Leuhmann, Davide Scozzi, et al. 2022. “Reprogramming Alveolar Macrophage Responses to TGF-β Reveals CCR2+ Monocyte Activity That Promotes Bronchiolitis Obliterans Syndrome.” Journal of Clinical Investigation 132 (19): 1–18. doi:10.1172/JCI159229.